By discovering how a type of smooth muscle forms in the gut, scientists have opened doors to making artificial muscle, repairing muscle following gut surgeries and treating inflammatory bowel disease and obesity.
Researchers comparing intestinal samples of children with Crohn’s disease and healthy children found one molecule that shows significant differences between the two groups.
Tim Barry ’93 co-founded a health care company that offers primary care, multispecialty and urgent care options to 1.6 million patients throughout the U.S.
Blocking the formation of filaments – multi-enzyme structures that fuel cancer activity – may offer new ways to control cancer cell proliferation, according to a new study led by Cornell researchers.
Researchers have developed an AI tool that uses machine learning and large language models to identify treatment options based on patients’ diagnoses, demographic information and priorities.
Weill Cornell Medicine researchers and Tanzanian colleagues are leveraging clergy's influence to lower life-threatening hypertension rates in Tanzania, and potentially the U.S.
Cornell food scientists show that a standard quality test used for raw, organic milk is insufficient for distinguishing between specific groups of bacteria -- suggesting that criteria needs updating.
Professor Sean Nicholson, director of the Cornell Sloan Program in Health Administration, explores the future of biopharma with industry experts in the Keynote webcast “Bringing New Science to Market.”